This is the authors' abstract. We don't add key points for this paper.
Intravenous artesunate improves survival in severe malaria, but clinical trial data from nonendemic countries are scarce. The TropNet severe malaria database was analyzed to compare outcomes of artesunate vs quinine treatment. Artesunate reduced parasite clearance time and duration of intensive care unit and hospital treatment in European patients with imported severe malaria.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Kurth et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: